WARSAW, Ind., Sept. 13, 2018 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global leader in
musculoskeletal healthcare, today announced that its Board of
Directors has approved the payment of a quarterly cash dividend to
stockholders for the third quarter of 2018.
The cash dividend of $0.24 per
share is payable on October 31, 2018
to stockholders of record as of the close of business on
September 28, 2018. Future
declarations of dividends are subject to approval of the Board of
Directors and may be adjusted as business needs or market
conditions change.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global
leader in musculoskeletal healthcare. We design, manufacture and
market orthopaedic reconstructive products; sports medicine,
biologics, extremities and trauma products; office based
technologies; spine, craniomaxillofacial and thoracic products;
dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to
advance the pace of innovation. Our products and solutions help
treat patients suffering from disorders of, or injuries to, bones,
joints or supporting soft tissues. Together with healthcare
professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world
and sell products in more than 100 countries. For more information,
visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at
www.twitter.com/zimmerbiomet.
ZBH-Fin
View original content to download
multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-third-quarter-of-2018-300711295.html
SOURCE Zimmer Biomet Holdings, Inc.